Literature DB >> 26758477

Sex differences in the effect of HbA1c-defined diabetes on a wide range of cardiovascular disease risk factors.

Tingting Du1, Gang Yuan1, Xinrong Zhou1, Xingxing Sun2.   

Abstract

OBJECTIVE: Sex differences in the association of HbA1c and cardiovascular disease (CVD) risk remain controversial. We examined CVD risk profile in both HbA1c-defined diabetic and nondiabetic men and women.
METHODS: We conducted a cross-sectional analysis of 7139 Chinese adults using data from the China Health and Nutrition Survey 2009.
RESULTS: HbA1c-defined nondiabetic men have a more favorable CVD risk profile than female counterparts. However, HbA1c-defined diabetic men have higher levels of triglyceride, low-density lipoprotein (LDL)-cholesterol, and triglyceride/high-density lipoprotein (HDL)-cholesterol and lower levels of HDL-cholesterol, be more visceral obese as indicated by visceral adiposity index (VAI) and lipid accumulation product (LAP), and more insulin resistant as assessed by the triglycerides and glucose index (TyG) than HbA1c-defined diabetic women. Furthermore, HbA1c-defined diabetic men showed greater relative differences in ferritin than diabetic women when compared with their nondiabetic counterparts. Statistically significant sex by HbA1c-defined diabetes status interactions were observed for triglyceride, LDL-cholesterol, HDL-cholesterol, triglyceride/HDL cholesterol, VAI, LAP, TyG, and ferritin (all ps < 0.05). Consideration of VAI or homeostasis model assessment of insulin resistance or both failed to eliminate the sex differences in the associations between diabetes and these CVD risk factors.
CONCLUSIONS: Men who progressed from HbA1c-defined nondiabetes to HbA1c-defined diabetes have greater metabolic deteriorations and put on more visceral adiposity than women. Key messages HbA1c-defined nondiabetic men have a more favorable CVD risk profile than female counterparts. Men have to undergo a greater metabolic deterioration to develop HbA1c-defined diabetes than do women. Men have to put on more visceral adiposity to develop HbA1c-defined diabetes than do women.

Entities:  

Keywords:  Cardiovascular risk factors; HbA1c; diabetes; sex

Mesh:

Substances:

Year:  2016        PMID: 26758477      PMCID: PMC5471318          DOI: 10.3109/07853890.2015.1127406

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  27 in total

1.  Cohort Profile: The China Health and Nutrition Survey--monitoring and understanding socio-economic and health change in China, 1989-2011.

Authors:  Barry M Popkin; Shufa Du; Fengying Zhai; Bing Zhang
Journal:  Int J Epidemiol       Date:  2009-11-03       Impact factor: 7.196

2.  The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp.

Authors:  Fernando Guerrero-Romero; Luis E Simental-Mendía; Manuel González-Ortiz; Esperanza Martínez-Abundis; María G Ramos-Zavala; Sandra O Hernández-González; Omar Jacques-Camarena; Martha Rodríguez-Morán
Journal:  J Clin Endocrinol Metab       Date:  2010-05-19       Impact factor: 5.958

3.  Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c.

Authors:  Kasia J Lipska; Nathalie De Rekeneire; Peter H Van Ness; Karen C Johnson; Alka Kanaya; Annemarie Koster; Elsa S Strotmeyer; Bret H Goodpaster; Tamara Harris; Thomas M Gill; Silvio E Inzucchi
Journal:  J Clin Endocrinol Metab       Date:  2010-09-22       Impact factor: 5.958

4.  Type II diabetes abrogates sex differences in endothelial function in premenopausal women.

Authors:  H O Steinberg; G Paradisi; J Cronin; K Crowde; A Hempfling; G Hook; A D Baron
Journal:  Circulation       Date:  2000-05-02       Impact factor: 29.690

5.  Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.

Authors:  Elizabeth Selvin; Michael W Steffes; Hong Zhu; Kunihiro Matsushita; Lynne Wagenknecht; James Pankow; Josef Coresh; Frederick L Brancati
Journal:  N Engl J Med       Date:  2010-03-04       Impact factor: 91.245

6.  Diabetes and all-cause and coronary heart disease mortality among US male physicians.

Authors:  P A Lotufo; J M Gaziano; C U Chae; U A Ajani; G Moreno-John; J E Buring; J E Manson
Journal:  Arch Intern Med       Date:  2001-01-22

7.  The relationship between {beta}-cell function and glycated hemoglobin: results from the veterans administration genetic epidemiology study.

Authors:  Mustafa Kanat; Diedre Winnier; Luke Norton; Nazik Arar; Chris Jenkinson; Ralph A Defronzo; Muhammad A Abdul-Ghani
Journal:  Diabetes Care       Date:  2011-02-23       Impact factor: 19.112

8.  Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events?

Authors:  Rebecca K Simmons; Stephen Sharp; S Matthijs Boekholdt; Lincoln A Sargeant; Kay-Tee Khaw; Nicholas J Wareham; Simon J Griffin
Journal:  Arch Intern Med       Date:  2008-06-09

9.  Diabetes, abdominal adiposity, and atherogenic dyslipoproteinemia in women compared with men.

Authors:  Ken Williams; Andre Tchernof; Kelly J Hunt; Lynne E Wagenknecht; Steven M Haffner; Allan D Sniderman
Journal:  Diabetes       Date:  2008-09-22       Impact factor: 9.461

10.  The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison.

Authors:  Henry S Kahn
Journal:  BMC Cardiovasc Disord       Date:  2005-09-08       Impact factor: 2.298

View more
  8 in total

1.  Differential sex effects of systolic blood pressure and low-density lipoprotein cholesterol on type 2 diabetes: Life course data from the Bogalusa Heart Study.

Authors:  Benjamin D Pollock; Wei Chen; Emily W Harville; Tian Shu; Vivian Fonseca; Franck Mauvais-Jarvis; Tanika N Kelly; Lydia A Bazzano
Journal:  J Diabetes       Date:  2017-04-06       Impact factor: 4.006

2.  Subsite-specific association of DEAD box RNA helicase DDX60 with the development and prognosis of oral squamous cell carcinoma.

Authors:  Ting-Ying Fu; Chao-Nan Wu; Huei-Cin Sie; Jiin-Tsuey Cheng; Yaoh-Shiang Lin; Huei-Han Liou; Yu-Kai Tseng; Chih-Wen Shu; Kuo-Wang Tsai; Leing-Ming Yen; Hui-Wen Tseng; Ching-Jiunn Tseng; Luo-Ping Ger; Pei-Feng Liu
Journal:  Oncotarget       Date:  2016-12-20

3.  Urine Glucose Excretion Attenuates the Association Between Lipid Accumulation Product and Serum Uric Acid in Subjects with Prediabetes.

Authors:  Juan Chen; Yu Liu; Haijian Guo; Bei Wang; Zilin Sun; Jiangyi Yu
Journal:  Diabetes Metab Syndr Obes       Date:  2020-06-30       Impact factor: 3.168

4.  Mendelian Randomization Analysis Support Causal Associations of HbA1c with Circulating Triglyceride, Total and Low-density Lipoprotein Cholesterol in a Chinese Population.

Authors:  Xu Jia; Yanan Hou; Min Xu; Zhiyun Zhao; Liping Xuan; Tiange Wang; Mian Li; Yu Xu; Jieli Lu; Yufang Bi; Weiqing Wang; Yuhong Chen
Journal:  Sci Rep       Date:  2019-04-02       Impact factor: 4.379

5.  The U-Shape Relationship Between Glycated Hemoglobin Level and Long-Term All-Cause Mortality Among Patients With Coronary Artery Disease.

Authors:  Liwei Liu; Jianfeng Ye; Ming Ying; Qiang Li; Shiqun Chen; Bo Wang; Yihang Lin; Guanzhong Chen; Zhubin Lun; Haozhang Huang; Huangqiang Li; Danyuan Xu; Ning Tan; Jiyan Chen; Jin Liu; Yong Liu
Journal:  Front Cardiovasc Med       Date:  2021-02-26

6.  Skeletal manifestations in a streptozotocin-induced C57BL/6 model of Type 1 diabetes.

Authors:  Jennifer M Hatch; Dyann M Segvich; Rachel Kohler; Joseph M Wallace
Journal:  Bone Rep       Date:  2022-08-01

7.  Distribution of glycated haemoglobin and its determinants in Korean youth and young adults: a nationwide population-based study.

Authors:  Ji-Young Seo; Seung-Sik Hwang; Jae Hyun Kim; Young Ah Lee; Seong Yong Lee; Choong Ho Shin; Sei Won Yang
Journal:  Sci Rep       Date:  2018-01-31       Impact factor: 4.379

8.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.